Fiche centre
New England Institute for Neurology and Headache
Stamford — United States
Essais liés4clinical trials
VilleStamfordlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03927144
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| AMG334 | Migraine | Phase 4 | NCT03927144 | Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients | COMPLETED |
| Dihydroergotamine | Migraine | Phase 3 | NCT03901482 | EMERGE — A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | COMPLETED |
| sumatriptan nasal powder | Migraine | Phase 3 | NCT03338920 | Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents | TERMINATED |
| EVO756, Dose 1 | Migraine | Phase 2 | NCT07616128 | Study of EVO756 in Adults With Migraine | RECRUITING |